Patented dodecapeptide tag enables low-cost, high-purity protein purification
Purify recombinant proteins at 15 mg yield with >90% purity; Isolate immune cells using multiple antigen criteria; Automate cell activation and expansion for gene therapies; Perform high-throughput screening of protein interactions; Enable closed-system, antibody-free cell isolation
Awarded UW Environmental Health & Safety Lab Safety Award; Received $1.7M grant from Andy Hill CARE Fund to commercialize cell therapy platform; Supports isolation of over 20 cell subtypes; Patented dodecapeptide technology with micromolar affinity for silica substrates